Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / R•••••••• H•••••• I•••

R•••••••• H•••••• I•••

Series ACarlsbad, CABiotechnology
Facts
Year of incorporation
2023sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
3
Disclosed raised
$20.0Msum of rounds with a disclosed amount only
Named investors
2
Financing history
3 rounds
  1. Jun 23, 2026
    Series A · $20.0M (disclosed)
    W••••••• P••••••• (lead)G••••••• G••••• I••••••••• L• (lead)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “R•••••••• H••••• Raises $20 Million in Series A Financing to Redefine the Future of Longevity-Based Skin H•••••”
  2. Jun 22, 2026
    Form D equity offering · $19.1M (form d sold) · 28 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “R•••••••• H•••••• I••• filed Form D: $19,112,746 sold of $24,999,999, Biotechnology”
  3. Dec 22, 2023
    Form D equity offering · $8.0M (form d sold)
    Fact SEC EDGAR Form D data sets (quarterly) · “R•••••••• H•••••• I••• filed Form D: $8,000,000 sold of $8,000,000, Biotechnology”
Investors on record
2 edges
People
4 officers, 11 directors
Timeline
4
  1. Jun 26, 2026
    R•••••••• H•••••• I••• filed Form D: $19,112,746 sold of $24,999,999, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Jun 23, 2026
    R•••••••• H••••• announced Series A of $20,000,000, led by W••••••• P•••••••, G•••••MD Global Investments
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
  3. Jun 4, 2025
    R•••••••• H•••••• I••• filed Form D/A: $9,079,616 sold of $13,500,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  4. Jan 17, 2024
    R•••••••• H•••••• I••• filed Form D: $8,000,000 sold of $8,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
46 observations
Every observation on this company